Sudan's renewed medtech prospects on hold:
This article was originally published in Clinica
Ongoing instability in the Darfur region of Sudan has put paid to any immediate prospect of resuming much-needed healthcare improvements. The situation has essentially obviated the calls made in July to meet shortfalls in medical supplies, diagnostic services and hospital infrastructures (see Clinica No 1117, p 13). International efforts were expected to resume last week, when the government signed a series of security and humanitarian access agreements, in response to widespread condemnation of the severe social instability in the region. The UN Security Council is due to meet on November 18, in Nairobi, Kenya, to discuss the situation and consider sanctions.
You may also be interested in...
GSK creates another partnership centered on its vaccine adjuvant technology, this time with China's Xiamen Innovax.
Lab testing for COVID-19 has risen to a new high of 314,000 tests per week in Germany, where the concerns are perhaps less about test availability than staff numbers to oversee the testing protocols.
A new European Commission guidance document explains the regulatory basics and much- altered emergency market entry criteria for new entrants to devices sector amid the COVID-19 crisis.